FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On February 21, 2007
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2003N-0400 Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2007M-0058 P050007/S001 - StarClose Vascular Closure System, Model 1004, Version 2.10
2007N-0005 Prescription Drug User Fee Act (PDUFA): Public Meeting
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 18731 Perrigo Company of South Carolina Vol #: 169
LET 18732 Perrigo Company of South Carolina Vol #: 169
LET 18733 Perrigo Company of South Carolina Vol #: 169
LET 18734 Perrigo Company of South Carolina Vol #: 169
LET 18735 Perrigo Company of South Carolina Vol #: 169
LET 18736 NBTY Inc. Vol #: 169
LET 18737 NBTY Inc. Vol #: 169
LET 18738 NBTY Inc. Vol #: 169
LET 18739 NBTY Inc. Vol #: 169
LET 18740 NBTY Inc. Vol #: 169
LET 18741 NBTY Inc. Vol #: 169
LET 18742 NBTY Inc. Vol #: 169
LET 18743 Perrigo Company of South Carolina Vol #: 169
LET 18744 Perrigo Company of South Carolina Vol #: 169
LET 18745 Arthur Andrew Medicals, Inc. Vol #: 170
LET 18746 Traditional Medicinals, Inc. Vol #: 170
LET 18747 Traditional Medicinals, Inc. Vol #: 170
LET 18748 PuraPharm Corporation Vol #: 170
LET 18749 PuraPharm Corporation Vol #: 170
LET 18750 PuraPharm Corporation Vol #: 170
LET 18751 PuraPharm Corporation Vol #: 170
LET 18752 PuraPharm Corporation Vol #: 170
LET 18753 PuraPharm Corporation Vol #: 170
LET 18754 PuraPharm Corporation Vol #: 170
LET 18755 PuraPharm Corporation Vol #: 170
LET 18756 PuraPharm Corporation Vol #: 170
LET 18757 PuraPharm Corporation Vol #: 170
LET 18758 PuraPharm Corporation Vol #: 170
LET 18759 PuraPharm Corporation Vol #: 170
LET 18760 PuraPharm Corporation Vol #: 170
LET 18761 PuraPharm Corporation Vol #: 170
LET 18762 PuraPharm Corporation Vol #: 170
LET 18763 PuraPharm Corporation Vol #: 170
LET 18764 PuraPharm Corporation Vol #: 170
LET 18765 PuraPharm Corporation Vol #: 170
LET 18766 PuraPharm Corporation Vol #: 170
LET 18767 PuraPharm Corporation Vol #: 170
LET 18768 PuraPharm Corporation Vol #: 170
LET 18769 PuraPharm Corporation Vol #: 170
LET 18770 PuraPharm Corporation Vol #: 170
LET 18771 PuraPharm Corporation Vol #: 170
LET 18772 PuraPharm Corporation Vol #: 170
LET 18773 PuraPharm Corporation Vol #: 170
LET 18774 PuraPharm Corporation Vol #: 170
LET 18775 PuraPharm Corporation Vol #: 170
LET 18776 PuraPharm Corporation Vol #: 170
LET 18777 PuraPharm Corporation Vol #: 170
LET 18778 PuraPharm Corporation Vol #: 170
LET 18779 PuraPharm Corporation Vol #: 170
LET 18780 PuraPharm Corporation Vol #: 170
LET 18781 PuraPharm Corporation Vol #: 170
LET 18782 PuraPharm Corporation Vol #: 170
LET 18783 PuraPharm Corporation Vol #: 170
LET 18784 PuraPharm Corporation Vol #: 170
LET 18785 PuraPharm Corporation Vol #: 170
LET 18786 PuraPharm Corporation Vol #: 170
LET 18787 PuraPharm Corporation Vol #: 170
LET 18788 PuraPharm Corporation Vol #: 170
LET 18789 PuraPharm Corporation Vol #: 170
LET 18790 PuraPharm Corporation Vol #: 170
LET 18791 PuraPharm Corporation Vol #: 170
LET 18792 PuraPharm Corporation Vol #: 170
LET 18793 PuraPharm Corporation Vol #: 170
LET 18794 PuraPharm Corporation Vol #: 170
LET 18795 PuraPharm Corporation Vol #: 170
LET 18796 PuraPharm Corporation Vol #: 170
LET 18797 PuraPharm Corporation Vol #: 170
LET 18798 PuraPharm Corporation Vol #: 170
LET 18799 PuraPharm Corporation Vol #: 170
LET 18800 PuraPharm Corporation Vol #: 170
LET 18801 PuraPharm Corporation Vol #: 170
LET 18802 PuraPharm Corporation Vol #: 170
LET 18803 PuraPharm Corporation Vol #: 170
LET 18804 PuraPharm Corporation Vol #: 170
LET 18805 PuraPharm Corporation Vol #: 170
LET 18806 PuraPharm Corporation Vol #: 170
LET 18807 PuraPharm Corporation Vol #: 170
2003N-0400 Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
BKG 2 Background Information Vol #: 15
NEC 1 FDA Vol #: 15
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
C 322 C. Grubb Vol #: 8
C 323 K. Ailor Vol #: 8
C 324 S. Sobel Vol #: 8
C 325 L. Tosti Vol #: 8
C 326 L. Knight Vol #: 8
C 327 J. Appelbaum Vol #: 8
C 328 C. Urban Vol #: 8
C 329 M. Sullivan Vol #: 8
C 330 S. Abernethy Vol #: 8
C 331 R. Jacobson Vol #: 8
C 332 J. Bennett Vol #: 8
C 333 M. Finelli Vol #: 8
C 334 D. Brown Vol #: 8
C 335 J. Hancley Vol #: 8
C 336 J. Janicke Vol #: 8
C 337 M. Mock Vol #: 8
C 338 H. Bruce Vol #: 8
C 339 J. Back Vol #: 8
C 340 J. Gilchrist Vol #: 8
C 341 B. Gaab Vol #: 8
C 342 A. Noland Vol #: 8
C 343 J. King Vol #: 8
C 344 N. Markham Vol #: 8
C 345 A. Vicker Vol #: 8
C 346 R. Lutz Vol #: 8
C 347 A. Neville Vol #: 8
C 348 B. Schueller Vol #: 8
C 349 D. Keep Vol #: 8
C 350 C. Boyer Vol #: 8
C 351 A. Nicol Vol #: 8
C 352 V. Schetler Vol #: 8
C 353 M. Ashe Vol #: 8
C 354 P. Greenwald Vol #: 8
C 355 S. Bradfield Vol #: 8
C 356 R. Powers Vol #: 8
C 357 L. Thacker Vol #: 8
C 358 M. Hedrick Vol #: 8
C 359 G. & H Horejsi Vol #: 8
C 360 A. & J. Brooks Vol #: 8
C 361 G. Marsh Vol #: 8
C 362 L. Hopkins Vol #: 8
C 363 E. Herro Vol #: 8
C 364 S. Bouvier Vol #: 8
C 365 C. Perry Vol #: 8
C 366 R. Nathan Vol #: 8
C 367 C. Maloney Vol #: 8
C 368 J. Hayes Vol #: 8
C 369 S. Bouvier Vol #: 8
C 370 J. Alexander Vol #: 8
C 371 S. S. Cronan Vol #: 8
C 372 V. James Vol #: 8
C 373 N. Schoenfeld Vol #: 8
C 374 L. Blakesley Vol #: 8
C 375 J. Cahn Vol #: 8
C 376 D. Selewach Vol #: 8
C 377 K. Merola Vol #: 8
C 378 S. Touillon Vol #: 8
C 379 I. Welch Vol #: 8
C 380 S. Henderson Vol #: 8
C 381 S. Fioravante Vol #: 8
C 382 B. Murr Vol #: 8
C 383 L. Heloskie Vol #: 8
C 384 A. Lange Vol #: 8
C 385 M. Lewis Vol #: 8
C 386 T. Jarvis Vol #: 8
C 387 C. Welker Vol #: 8
C 388 S. Conover Vol #: 8
C 389 L. May Vol #: 8
C 390 M. & G. Denton Vol #: 8
C 391 A. LeBlanc Vol #: 8
C 392 P. Filipski Vol #: 8
C 393 A. Rinaldi Vol #: 8
C 394 no signature Vol #: 8
C 395 J. Grauer Vol #: 8
C 396 J. Grauer Vol #: 8
C 397 N. Dumas Vol #: 8
C 398 C. Stras Vol #: 8
C 399 D. Pixley Vol #: 8
C 400 C. Cooper Vol #: 8
C 401 M. Sovo Vol #: 9
C 402 W. Packwood Vol #: 9
C 403 D. Messinger Vol #: 9
C 404 R. Amendola Vol #: 9
C 405 T. Grassi Vol #: 9
C 406 no signature Vol #: 9
C 407 L. Ashlee Vol #: 9
C 408 C. Suartpneldi Vol #: 9
C 409 S. Montel Vol #: 9
C 410 C. Logan Vol #: 9
C 411 R. Iannacone Vol #: 9
C 412 B. Nixon Vol #: 9
C 413 E. Lombardo Vol #: 9
C 414 R. Bateman Vol #: 9
C 415 A. Kepich Vol #: 9
C 416 K. Ballard Vol #: 9
C 417 S. Cheney Vol #: 9
C 418 J. Westervelt Vol #: 9
C 419 J. Leclerc Vol #: 9
C 420 no signature Vol #: 9
C 421 F. Bahrami Vol #: 9
C 422 J. Boldizar Vol #: 9
C 423 S.Cava Vol #: 9
C 424 L. Sharinay Vol #: 9
C 425 J. Jackson Vol #: 9
C 426 R. Schelling Vol #: 9
C 427 C. Canella Vol #: 9
C 428 D. Lisi Vol #: 9
C 429 G. Naccarato Vol #: 9
C 430 R. Mirvis Vol #: 9
C 431 A. Chavez Vol #: 9
C 432 D. Wurst Vol #: 9
C 433 C. Holt Vol #: 9
C 434 M. Stavish Vol #: 9
C 435 J. Crouch Vol #: 9
C 436 A. Nebel Vol #: 9
C 437 L. Wallace Vol #: 9
C 438 no signature Vol #: 9
C 439 no signature Vol #: 9
C 440 E. Mesick Vol #: 9
C 441 J. Warriner Vol #: 9
C 442 C. Haessiq Vol #: 9
C 443 S. Hall Vol #: 9
C 444 I. Putz Vol #: 9
C 445 R. Odrobina Vol #: 9
C 446 G. Priesler Vol #: 9
C 447 R. Gilman Vol #: 9
C 448 T. Seastrom Vol #: 9
C 449 H. Fraser Vol #: 9
C 450 J. Lacasse Vol #: 9
C 451 J. MacMillan Vol #: 9
C 452 S. Crocker Vol #: 9
C 453 G. Scott Vol #: 9
C 454 J. Menefee Vol #: 9
C 455 D. Preller Vol #: 9
C 456 J. Mardirosian Vol #: 9
C 457 A. Barbier Vol #: 9
C 458 L. Graham Vol #: 9
C 459 B. Bledsoe Vol #: 9
C 460 R. Carrothers Vol #: 9
C 461 B. Oaubius Vol #: 9
C 462 J. & P Schonig Vol #: 9
C 463 J. Carver Vol #: 9
C 464 L. White Vol #: 9
C 465 P. Church Vol #: 9
C 466 B. Raglan Vol #: 9
C 467 J. Priest Vol #: 9
C 468 E. Egbert Vol #: 9
C 469 C. Stubbs Vol #: 9
C 470 no signature Vol #: 9
C 471 S. Lagow Vol #: 9
C 472 L. Hoto Vol #: 9
C 473 J. Ikola Vol #: 9
C 474 V. Snyder Vol #: 9
C 475 S. Burghause Vol #: 9
C 476 M. Griffith Vol #: 9
C 477 B. Bonsigmore Vol #: 9
C 478 E. Anderson Vol #: 9
C 479 E. Goehringer Vol #: 9
C 480 P. Green Vol #: 9
C 481 A. A. Friends Vol #: 9
C 482 K. Baytos Vol #: 9
C 483 N. Curias Vol #: 9
C 484 M. Dinallo Vol #: 9
C 485 M. Doty Vol #: 9
C 486 J. Cunning Vol #: 9
C 487 H. Campenella Vol #: 9
C 488 B. Bouder Vol #: 9
C 489 R. Blake Vol #: 9
C 490 E. Mulbry Vol #: 9
C 491 S. V Vol #: 9
C 492 R. Hoover Vol #: 9
C 493 K. Merloa Vol #: 9
C 494 S. Cronan Vol #: 9
C 495 J. Figurski Vol #: 9
C 496 I. Rebelle Vol #: 9
C 497 C. Lawless Vol #: 9
C 498 L. Nicola Vol #: 9
C 499 L. Greenleaf Vol #: 9
C 500 P. Shaw Vol #: 9
C 501 J. Colasuono Vol #: 9
C 502 F. Evans Vol #: 9
C 503 S. Snyder Vol #: 9
C 504 S. Hall Vol #: 9
C 505 A. Dotson Vol #: 9
C 506 C. Sutton Vol #: 9
C 507 T. Odum Vol #: 9
C 508 C. Dziewior Vol #: 9
C 509 D. Bump Vol #: 9
C 510 D. Funk Vol #: 9
C 511 L. McLaughlin Vol #: 9
C 512 R. Stein Vol #: 9
C 513 D. Brown Vol #: 9
C 514 S. Astin Vol #: 9
C 515 L. Setaro Vol #: 9
C 516 E. Humenik Vol #: 9
C 517 H. McVay Vol #: 9
C 518 R. Sudol Vol #: 9
C 519 C. Lindeke Vol #: 9
C 520 M. Anderson Vol #: 9
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18258 K. Pautler Vol #: 198
2007M-0058 P050007/S001 - StarClose Vascular Closure System, Model 1004, Version 2.10
AAV 1 Abbott Vascular Devices Vol #: 1
2007N-0005 Prescription Drug User Fee Act (PDUFA): Public Meeting
TS 1 Prescription Drug User Fee Act (PDUFA IV) Vol #: 1
TS 2 FDA - User-Fee Funding of Human Drug Review Vol #: 1
TS 3 K Witczak Vol #: 1
TS 4 Consumers Union Vol #: 1
TS 5 Plasma Protein Therapeutics Association (PPTA) Vol #: 1
TS 6 U S Chamber of Commerce Vol #: 1
TS 7 Committee of Ten Thousand Vol #: 1
TS 8 AHRP Vol #: 1
TS 9 Coalition for Healthcare Communication Vol #: 1
TS 10 Biotechnology Industry Organization Vol #: 1
TS 11 Academy of Managed Care Pharmacy Vol #: 1
TS 12 Drug Safety Institute Vol #: 1
TS 13 Biotechnology Industry Organization Vol #: 1
TS 14 National Research Center for Women & Families Vol #: 1
TS 15 American Society of Health-Systems Pharmacists Vol #: 1
TS 16 Mental Health America Vol #: 1
TS 17 Council on Radionuclides and Radiopharmaceuticals (CORAR) Vol #: 1
TS 18 W DeCamp Vol #: 1

Page created on February 21, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management